Jeanne Saraiva da Paz

Jeanne Saraiva da Paz

Auto-generated profile, based on publicly available information

Jeanne Saraiva da Paz

Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2018 in Science
Verified
Journal Article
Closed access
PDF file
IVIlia D. Vainchtein
Ilia D. Vainchtein
GCGregory Chin
Gregory Chin
FCFrances S. Cho
Frances S. Cho
KKKevin W. Kelley
Kevin W. Kelley
JMJohn G. Miller
John G. Miller
AMAnna V. Molofsky
Anna V. Molofsky
Call to action: The developing brain initially makes more synapses than it needs. With further development, excess synapses are pruned away, leaving mature circuits. Synapses can be eliminated by microglia, which engulf and destroy them. Vainchtein et al. found that the microglia are called into action by astrocytes, supportive cells on which neurons rely. Astrocytes near a redundant synapse release the cytokine interleukin-33 (IL-33), which recruits microglia to the site. In mice, disruptions in this process, as caused by deficiency in IL-33, led to too many excitatory synapses and overactive brain circuitry. Science , this issue p. 1269

1 June 2017 in Cell Reports
Verified
Journal Article
Open access
ACAlexandra Clemente-Perez
Alexandra Clemente-Perez
SMStefanie Ritter Makinson
Stefanie Ritter Makinson
BHBryan Higashikubo
Bryan Higashikubo
SBScott Brovarney
Scott Brovarney
FCFrances S. Cho
Frances S. Cho
JPJeanne T. Paz
Jeanne T. Paz
Integrative brain functions depend on widely distributed, rhythmically coordinated computations. Through its long-ranging connections with cortex and most senses, the thalamus orchestrates the flow of cognitive and sensory information. Essential in this process, the nucleus reticularis thalami (nRT) gates different information streams through its extensive inhibition onto other thalamic nuclei, however, we lack an understanding of how different inhibitory neuron subpopulations in nRT function as gatekeepers. We dissociated the connectivity, physiology, and circuit functions of neurons within rodent nRT, based on parvalbumin (PV) and somatostatin (SOM) expression, and validated the existence of such populations in human nRT. We found that PV, but not SOM, cells are rhythmogenic, and that PV and SOM neurons are connected to and modulate distinct thalamocortical circuits. Notably, PV, but not SOM, neurons modulate somatosensory behavior and disrupt seizures. These results provide a conceptual framework for how nRT may gate incoming information to modulate brain-wide rhythms.

10 September 2021 in Science
Verified
Journal Article
Closed access
SHStephanie S. Holden
Stephanie S. Holden
FGFiorella C. Grandi
Fiorella C. Grandi
OAOumaima Aboubakr
Oumaima Aboubakr
BHBryan Higashikubo
Bryan Higashikubo
FCFrances S. Cho
Frances S. Cho
JPJeanne T. Paz
Jeanne T. Paz
Neuroinflammation after brain injury: Traumatic brain injury affects millions of people every year and is a major cause of disability worldwide. Most of the maladaptive outcomes develop months or years later and are thought to be caused by secondary injuries that are indirect and long-term effects after the initial impact. Holden et al . found that secondary and chronic neuroinflammation and neurodegeneration are caused by the C1q molecule, a mediator of the complement pathway. C1q is responsible for chronic inflammation and secondary neuronal loss specifically in the cortico-thalamo-cortical circuit. Traumatic brain injury also leads to altered brain states that are caused by the C1q complement pathway. —PRS

1 January 2017 in Neuron
Verified
Journal Article
Closed access
JSJordan M. Sorokin
Jordan M. Sorokin
TDThomas J. Davidson
Thomas J. Davidson
EFEric Frechette
Eric Frechette
AAArmen M. Abramian
Armen M. Abramian
KDKarl Deisseroth
Karl Deisseroth
JPJeanne T. Paz
Jeanne T. Paz

27 March 2023 in Neurobiology of Disease
Verified
Journal Article
Open access
BLBritta E. Lindquist
Britta E. Lindquist
CTClare Timbie
Clare Timbie
YVYuliya Voskobiynyk
Yuliya Voskobiynyk
JPJeanne T. Paz
Jeanne T. Paz
Generalized epilepsy affects 24 million people globally; at least 25% of cases remain medically refractory. The thalamus, with widespread connections throughout the brain, plays a critical role in generalized epilepsy. The intrinsic properties of thalamic neurons and the synaptic connections between populations of neurons in the nucleus reticularis thalami and thalamocortical relay nuclei help generate different firing patterns that influence brain states. In particular, transitions from tonic firing to highly synchronized burst firing mode in thalamic neurons can cause seizures that rapidly generalize and cause altered awareness and unconsciousness. Here, we review the most recent advances in our understanding of how thalamic activity is regulated and discuss the gaps in our understanding of the mechanisms of generalized epilepsy syndromes. Elucidating the role of the thalamus in generalized epilepsy syndromes may lead to new opportunities to better treat pharmaco-resistant generalized epilepsy by thalamic modulation and dietary therapy.

14 September 2020 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
EJErik C. B. Johnson
Erik C. B. Johnson
KHKaitlyn Ho
Kaitlyn Ho
GYGui-Qiu Yu
Gui-Qiu Yu
MDMelanie Das
Melanie Das
PSPascal E. Sanchez
Pascal E. Sanchez
LMLennart Mucke
Lennart Mucke
Background: Alzheimer’s disease (AD) is the most frequent and costly neurodegenerative disorder. Although diverse lines of evidence suggest that the amyloid precursor protein (APP) is involved in its causation, the precise mechanisms remain unknown and no treatments are available to prevent or halt the disease. A favorite hypothesis has been that APP contributes to AD pathogenesis through the cerebral accumulation of the amyloid-β peptide (Aβ), which is derived from APP through sequential proteolytic cleavage by BACE1 and γ-secretase. However, inhibitors of these enzymes have failed in clinical trials despite clear evidence for target engagement. Methods: To further elucidate the roles of APP and its metabolites in AD pathogenesis, we analyzed transgenic mice overexpressing wildtype human APP (hAPP) or hAPP carrying mutations that cause autosomal dominant familial AD (FAD), as well as App knock-in mice that do not overexpress hAPP but have two mouse App alleles with FAD mutations and a humanized Aβ sequence. Results: Although these lines of mice had marked differences in cortical and hippocampal levels of APP, APP C-terminal fragments, soluble Aβ, Aβ oligomers and age-dependent amyloid deposition, they all developed cognitive deficits as well as non-convulsive epileptiform activity, a type of network dysfunction that also occurs in a substantive proportion of humans with AD. Pharmacological inhibition of BACE1 effectively reduced levels of amyloidogenic APP C-terminal fragments (C99), soluble Aβ, Aβ oligomers, and amyloid deposits in transgenic mice expressing FAD-mutant hAPP, but did not improve their network dysfunction and behavioral abnormalities, even when initiated at early stages before amyloid deposits were detectable. Conclusions: hAPP transgenic and App knock-in mice develop similar pathophysiological alterations. APP and its metabolites contribute to AD-related functional alterations through complex combinatorial mechanisms that may be difficult to block with BACE inhibitors and, possibly, also with other anti-Aβ treatments.